| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| X4 Pharmaceuticals, Inc | Director | Common Stock | 4,722 | $897 | $0.1900 | 09 Jun 2025 | Direct |
| X4 Pharmaceuticals, Inc | Director | Stock Option (right to buy) | 0 | 01 Jan 2026 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| XFOR | X4 Pharmaceuticals, Inc | 01 Jan 2026 | 1 | $0 | 4 | Director | 05 Jan 2026, 16:06 |
| XFOR | X4 Pharmaceuticals, Inc | 09 Jun 2025 | 1 | $0 | 4 | Director | 10 Jun 2025, 16:30 |
| XFOR | X4 Pharmaceuticals, Inc | 10 Jun 2024 | 1 | $0 | 4 | Director | 11 Jun 2024, 16:13 |
| XFOR | X4 Pharmaceuticals, Inc | 13 Jun 2023 | 1 | $0 | 4 | Director | 14 Jun 2023, 16:57 |
| XFOR | X4 Pharmaceuticals, Inc | 06 Jun 2022 | 1 | $0 | 4 | Director | 27 Jun 2022, 16:16 |
| XFOR | X4 Pharmaceuticals, Inc | 14 Oct 2021 | 1 | $0 | 4 | Director | 18 Oct 2021, 16:15 |
| XFOR | X4 Pharmaceuticals, Inc | 14 Oct 2021 | 0 | $0 | 3 | Director | 18 Oct 2021, 16:14 |